Business Standard

DLF dips on disappointing Q2 earnings

Q2 net prodit down 63% at Rs 139 crore from Rs 372 crore in previous year quarter

Related News

DLF is trading lower by 2.4% at Rs 201 on the Bombay Stock Exchange after reporting 63% year-on-year (yoy) decline in its consolidated net profit at Rs 139 crore for the quarter ended September due to decline in sales.

Total income from operations of the country’s largest company has dropped 19% during the quarter to Rs 2,039 crore, compared to Rs 2,532 crore last year in the same period, said in a statement.

The stock opened at Rs 204 and has seen a combined 59,000 shares changing hands on the counter in opening deals on both the exchanges.

Read more on:   
|
|

DLF dips on disappointing Q2 earnings

Q2 net prodit down 63% at Rs 139 crore from Rs 372 crore in previous year quarter

DLF is trading lower by 2.4% at Rs 201 on the Bombay Stock Exchange after reporting 63% year-on-year (yoy) decline in its consolidated net profit at Rs 139 crore for the quarter ended September due to decline in sales.

DLF is trading lower by 2.4% at Rs 201 on the Bombay Stock Exchange after reporting 63% year-on-year (yoy) decline in its consolidated net profit at Rs 139 crore for the quarter ended September due to decline in sales.

Total income from operations of the country’s largest company has dropped 19% during the quarter to Rs 2,039 crore, compared to Rs 2,532 crore last year in the same period, said in a statement.

The stock opened at Rs 204 and has seen a combined 59,000 shares changing hands on the counter in opening deals on both the exchanges.

image

Read More

BSE launches carbon index

Premier bourse BSE, in collaboration with the UK government, today launched BSE Carbonex, the first-of-its-kind index in India or any emerging market ...

Recommended for you

Quick Links

Market News

Nickel rises by 0.1% on Asian cues

Traders strengthened positions amid a firming Asian cues

Oil prices rise further in Asia

Expectations of a decline in US crude inventories and robust economic data from the eurozone helped prices

Markets remain rangebound; HUL up over 2%, Hindalco dips 1%

Investors are optimistic about a possible solution between Greece and its international creditors to avert a debt crisis

Pharma shares in focus; Aurobindo Pharma hits new high

JB Chemicals, Alembic Pharma, Aurobindo Pharma, Ipca Laboratories and Dishman Pharma were up 3%-11% each.

Infinite Computer gains on board approval for share buyback proposal

The stock spurted 5% at Rs 171 after the board approved the buyback of shares at a maximum price of Rs 220 per share from the open market ...

 

Back to Top